Layla Zulfa

Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint novo-nordisks-ziltivekimab-hits-roadblock-phase-3-zeus-trial-fails-to-meet-primary-endpoint

Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint

Layla Zulfa September 3, 2026

In a significant setback for its burgeoning cardiovascular pipeline, Novo Nordisk has announced that ziltivekimab—an investigational human...

The Future of the Human Blueprint: Why Genetics Advocacy is Critical to Congressional Policy the-future-of-the-human-blueprint-why-genetics-advocacy-is-critical-to-congressional-policy

The Future of the Human Blueprint: Why Genetics Advocacy is Critical to Congressional Policy

Layla Zulfa September 3, 2026

In an era defined by rapid biotechnological advancement, the intersection of human genetics and public policy has...

Africa Leads the Charge: A Landmark $45 Million Pledge to Secure the Future of Global Health africa-leads-the-charge-a-landmark-45-million-pledge-to-secure-the-future-of-global-health

Africa Leads the Charge: A Landmark $45 Million Pledge to Secure the Future of Global Health

Layla Zulfa September 2, 2026

In a historic display of continental solidarity and forward-thinking diplomacy, 14 African nations and a coalition of...

Breakthrough in Cardiac Care: Vesalio’s enVast Clot Retriever Shows Significant Promise in NATURE Clinical Trial breakthrough-in-cardiac-care-vesalios-envast-clot-retriever-shows-significant-promise-in-nature-clinical-trial

Breakthrough in Cardiac Care: Vesalio’s enVast Clot Retriever Shows Significant Promise in NATURE Clinical Trial

Layla Zulfa August 31, 2026

The landscape of interventional cardiology is witnessing a potential paradigm shift following the unveiling of data from...

Beyond Survival: Johana’s Journey from Persecution to Purpose beyond-survival-johanas-journey-from-persecution-to-purpose

Beyond Survival: Johana’s Journey from Persecution to Purpose

Layla Zulfa August 31, 2026

For many, the concept of "home" is a physical location. For Johana, a resilient advocate and cancer...

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue strengthening-the-global-health-architecture-a-deep-dive-into-the-belgium-who-strategic-dialogue-2

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue

Layla Zulfa August 31, 2026

Introduction: A Renewed Commitment to Multilateralism In an era defined by rapid geopolitical shifts and intensifying global...

Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope breakthrough-in-glioblastoma-treatment-usc-researchers-uncover-potent-combination-therapy-offering-new-hope

Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope

Layla Zulfa August 31, 2026

LOS ANGELES, CA – [Insert Date] – A new study spearheaded by researchers at Keck Medicine of...

Beyond the Zen: How Doom Metal Yoga is Redefining the Modern Practice beyond-the-zen-how-doom-metal-yoga-is-redefining-the-modern-practice

Beyond the Zen: How Doom Metal Yoga is Redefining the Modern Practice

Layla Zulfa August 30, 2026

Published: August 30, 2026 In the quiet, industrial pockets of Portland, Oregon, a sonic experiment has been...

A New Frontier in Rare Disease: FDA Approves Lisraya for Dermatomyositis a-new-frontier-in-rare-disease-fda-approves-lisraya-for-dermatomyositis

A New Frontier in Rare Disease: FDA Approves Lisraya for Dermatomyositis

Layla Zulfa August 29, 2026

In a landmark decision for the rare disease community, the U.S. Food and Drug Administration (FDA) has...

Enlicitide’s Promising PCSK9 Inhibition for LDL-C Lowering: A Deep Dive into ESC 2026 Data enlicitides-promising-pcsk9-inhibition-for-ldl-c-lowering-a-deep-dive-into-esc-2026-data

Enlicitide’s Promising PCSK9 Inhibition for LDL-C Lowering: A Deep Dive into ESC 2026 Data

Layla Zulfa August 29, 2026

The European Society of Cardiology (ESC) Congress 2026 has once again served as a pivotal platform for...

Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint

The Future of the Human Blueprint: Why Genetics Advocacy is Critical to Congressional Policy

Africa Leads the Charge: A Landmark $45 Million Pledge to Secure the Future of Global Health

Breakthrough in Cardiac Care: Vesalio’s enVast Clot Retriever Shows Significant Promise in NATURE Clinical Trial

Beyond Survival: Johana’s Journey from Persecution to Purpose

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue

Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope

Beyond the Zen: How Doom Metal Yoga is Redefining the Modern Practice

A New Frontier in Rare Disease: FDA Approves Lisraya for Dermatomyositis

Enlicitide’s Promising PCSK9 Inhibition for LDL-C Lowering: A Deep Dive into ESC 2026 Data

You may have missed

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment